Lipid Panel blood test
Lipid Panel. Also called: Lipid profile, Cholesterol panel, Lipoprotein panel
A standard lipid panel measures total cholesterol, HDL and triglycerides and calculates LDL. ApoB and Lp(a) are advanced tests ordered separately. Fasting is not needed for any of them.
At a glance
| Standard panel | Total cholesterol, HDL and triglycerides are measured; LDL is calculated from them (Labcorp uses the NIH equation). |
|---|---|
| Advanced tests | ApoB and Lp(a), ordered separately. |
| Sample | Serum or plasma. Fasting is not needed. |
| How often | Every 5 years from age 20 (NCEP ATP III); Lp(a) at least once in adulthood (2026 ACC/AHA). |
| Peptides | GLP-1 drugs such as Tirzepatide lower triglycerides and ApoB; GnRH drugs such as Leuprolide raise cholesterol and triglycerides. |
| Lab code | LOINC 24331-1 (Labcorp 303756, Quest 7600) |
What is a Lipid Panel?
A lipid panel measures the fats in your blood that relate to heart risk. A standard panel measures total cholesterol, HDL cholesterol and triglycerides directly and calculates LDL from them; Labcorp now uses the NIH equation for that step. ApoB and Lp(a) are not on a standard panel. They are ordered as separate tests: ApoB when LDL may understate risk, Lp(a) once in adulthood.
Standard Lipid Panel
The four values on every standard panel. NCEP ATP III recommends a lipid profile every 5 years from age 20, and the panel does not need a fasting sample.
| Value | What it measures | Typical adult range | Details |
|---|---|---|---|
| Total cholesterolTotal cholesterol (TC) | All the cholesterol in LDL, HDL and the triglyceride-rich particles, added together | Desirable below 200 mg/dL; borderline high 200-239; high 240 or higher. Labcorp prints 100-199 mg/dL. | LOINC 2093-3Full Total cholesterol guide → [5] [7] [8] |
| LDL cholesterolLow-density lipoprotein cholesterol (LDL-C) | The cholesterol in LDL particles; usually calculated, sometimes measured directly | Optimal below 100 mg/dL; near optimal 100-129; borderline high 130-159; high 160-189; very high 190 or higher. Labcorp prints 0-99 mg/dL. | LOINC 2089-1Full LDL cholesterol guide → [5] [3] [9] [10] |
| HDL cholesterolHigh-density lipoprotein cholesterol (HDL-C) | The cholesterol in HDL particles | Low below 40 mg/dL; high 60 or higher (ATP III). Quest's adult limits: men 40 or higher, women 50 or higher. Labcorp prints above 39. | LOINC 2085-9Full HDL cholesterol guide → [5] [2] |
| TriglyceridesTriglycerides (TG) | The fat carried mainly in VLDL and chylomicrons | Normal below 150 mg/dL; borderline high 150-199; high 200-499; very high 500 or higher. Labcorp prints 0-149 mg/dL. | LOINC 2571-8Full Triglycerides guide → [5] [6] |
What high and low results usually point to
- Total cholesterol: high high LDL, a high HDL, or a secondary cause such as low thyroid; low usually cholesterol-lowering treatment
- LDL cholesterol: high inherited high cholesterol, diet or a secondary cause; the main treatment target; low the goal on treatment
- HDL cholesterol: high usually lower risk; low higher risk; part of the metabolic syndrome
- Triglycerides: high obesity, diabetes, alcohol, a recent meal or inherited causes; low rarely a concern
Advanced lipid tests
Ordered on their own, not on a standard panel. ApoB counts the particles that can build plaque and is measured selectively; Lp(a) is inherited, and one measurement in adulthood is usually enough.
The 2026 ACC/AHA guideline recommends measuring Lp(a) at least once in every adult: see the Lp(a) guide.
| Value | What it measures | Typical adult range | Details |
|---|---|---|---|
| ApoBApolipoprotein B | The number of LDL, VLDL-remnant and Lp(a) particles (one ApoB each) | Desirable below 90 mg/dL (Labcorp, Quest); 130 mg/dL or higher is high on Quest reports and was a risk-enhancing factor in the 2018 AHA/ACC guideline. | LOINC 1884-6Full ApoB guide → [13] [9] [14] |
| Lp(a)Lipoprotein(a) | LDL-like particles carrying apolipoprotein(a); mostly set by genes | Below 75 nmol/L low risk; 75-125 intermediate; 125 or higher high (Labcorp, Quest). 125 nmol/L or 50 mg/dL is a risk-enhancing factor. | LOINC 43583-4Full Lp(a) guide → [11] [15] [16] |
What high and low results usually point to
- ApoB: high more atherogenic particles than LDL may suggest, often with high triglycerides or diabetes; low the goal on treatment
- Lp(a): high inherited higher risk of heart disease and aortic stenosis; low no Lp(a)-attributable risk
Reading a Lipid Panel
Read the values together rather than one at a time. These are the patterns the guidelines describe.
High LDL
LDL is the main treatment target. The 2026 ACC/AHA guideline sets LDL goals by risk: below 100 mg/dL at borderline or intermediate risk, below 70 at high risk and below 55 at very high risk. Every adult with an LDL of 190 mg/dL or higher is eligible for a statin under both the 2018 and 2026 guidelines.
Sources: [12] [4] [17] [9] [5]
High triglycerides with low HDL
This pattern is part of the metabolic syndrome in ATP III. When triglycerides are 200 mg/dL or higher, ATP III adds non-HDL cholesterol as a second target, and calculated LDL is less accurate when triglycerides are very high.
Normal LDL, high ApoB
More particles than the LDL number suggests, each carrying less cholesterol. It is more common with high triglycerides, type 2 diabetes and obesity, which is when the 2026 ACC/AHA guideline suggests measuring ApoB.
Normal panel, high Lp(a)
Lp(a) is inherited and does not show on a standard panel. A high result is a reason to control LDL and other risk factors earlier and more intensively.
Peptides with published lipid data
Peptide data sits on the deep pages, one row per study, label or population. Counts are distinct peptides.
How the test works
| Sample | Serum or plasma, 1 mL at Labcorp. |
|---|---|
| Fasting | Not needed for the standard panel, ApoB or Lp(a). After normal meals, triglycerides rise by about 26 mg/dL at most and total and LDL cholesterol fall by about 8 mg/dL, while HDL, ApoB and Lp(a) do not change. A fasting sample is suggested when non-fasting triglycerides are above 440 mg/dL. |
| Timing | NCEP ATP III recommends a lipid profile every 5 years from age 20. The 2026 ACC/AHA guideline recommends measuring Lp(a) at least once in adulthood and ApoB selectively. |
| Lab differences | Cholesterol, HDL and triglycerides are measured enzymatically; LDL is usually calculated (Labcorp uses the NIH equation). ApoB and Lp(a) are measured by immunoassay. |
| Retesting | The 2026 ACC/AHA guideline reassesses lipids after starting or changing treatment, looking at both the percentage fall and the level reached. The 2018 guideline it replaced rechecked at 4 to 12 weeks, then every 3 to 12 months as needed. |
| Labcorp order code | 303756: Lipid Panel |
| Quest Diagnostics order code | 7600: Lipid Panel, Standard |
| LOINC codes |
|
FAQ
What is in a standard lipid panel?
Total cholesterol, HDL cholesterol and triglycerides, which are measured, and LDL cholesterol, which is usually calculated from them.
Do I need to fast for a lipid panel?
No. After normal meals triglycerides rise by about 26 mg/dL at most and LDL falls by about 8 mg/dL. A fasting sample is suggested when non-fasting triglycerides are above 440 mg/dL.
Sources: [6]
How often should I get a lipid panel?
NCEP ATP III recommends one every 5 years from age 20. On treatment, the 2026 ACC/AHA guideline reassesses after every change; the 2018 guideline it replaced rechecked at 4 to 12 weeks, then every 3 to 12 months.
Are ApoB and Lp(a) part of a lipid panel?
No. They are separate tests that have to be ordered on their own.
When is ApoB ordered?
When LDL may understate risk: the 2026 ACC/AHA guideline suggests it with triglycerides above 200 mg/dL, diabetes, or an LDL already below 70 mg/dL on treatment.
Sources: [4]
When is Lp(a) ordered?
At least once in adulthood, in the 2026 ACC/AHA guideline and the 2022 European consensus. Because it is inherited, one result is usually enough.
What is non-HDL cholesterol?
Total cholesterol minus HDL: the cholesterol in all the particles that can build plaque. ATP III uses it as a second target when triglycerides are 200 mg/dL or higher.
Sources: [5]
Why is LDL calculated instead of measured?
It is cheaper and accurate in most people. The NIH equation that Labcorp uses was built to stay accurate when LDL is low or triglycerides are high; a direct LDL test is available when needed.
Do GLP-1 drugs change the lipid panel?
Mostly triglycerides: in their obesity trials they fell 29.1% on Tirzepatide 15 mg and 21.9% on Semaglutide 2.4 mg, with smaller changes in LDL and HDL. Tirzepatide also lowered ApoB in a diabetes trial.
Can peptides make a lipid panel worse?
GnRH drugs can. The Leuprolide label records hyperlipidemia in 5% or more of men with prostate cancer, and Goserelin raised LDL in women treated for endometriosis.
References
- Labcorp. Test 303756: Lipid Panel. Components, specimen, patient preparation and LOINC map. labcorp.com/tests/303756/lipid-panel
- Quest Diagnostics. Test 7600: Lipid Panel, Standard. Test directory: components, patient preparation, methodology and age- and sex-specific reference ranges. testdirectory.questdiagnostics.com/test/test-detail/7600/lipid-panel-standard?cc=PHP
- Sampson M, Ling C, Sun Q, et al. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540-548. PMID 32101259
- Sabouret P, Mafrica D, Giamundo DM, et al. The 2026 ACC/AHA Dyslipidemia Guideline: A Critical and Transatlantic Perspective on Personalized Lipid Management. Life (Basel). 2026;16(9). PMID 42795336
- National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary. NIH Publication No. 01-3670. National Heart, Lung, and Blood Institute; 2001. Table 2 (LDL, total and HDL cholesterol classification), triglyceride classification and Table 8 (metabolic syndrome). nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf
- Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58. PMID 27122601
- Labcorp. Sample report, test 303756 (Lipid Panel): reference intervals as printed for a 31-year-old woman (reported 06/10/2024). files.labcorp.com/testmenu-d8/sample_reports/303756.pdf
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. PMID 11368702
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. PMID 30586774
- Abifadel M, Varret M, Rabès JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34(2):154-6. PMID 12730697
- Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946. PMID 36036785
- Writing Committee Members, Blumenthal RS, Morris PB, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;153(17):e1154-e1276. PMID 41824552
- Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295. PMID 31642874
- Marston NA, Giugliano RP, Melloni GEM, et al. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. JAMA Cardiol. 2022;7(3):250-256. PMID 34773460
- Reyes-Soffer G, Ginsberg HN, Berglund L, et al. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(1):e48-e60. PMID 34647487
- Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361(26):2518-28. PMID 20032323
- Essa M, Malik D, Narula S, et al. Primary prevention statin eligibility for U.S. adults under the 2026 ACC/AHA dyslipidemia guideline. Am J Prev Cardiol. 2026;30:101709. PMID 42827841
- Labcorp. Test 167015: Apolipoprotein B. Methodology, specimen, risk categories and LOINC map. labcorp.com/tests/167015/apolipoprotein-b
- Labcorp. Test 120188: Lipoprotein(a). Methodology, specimen, patient preparation, limitations and LOINC map. labcorp.com/tests/120188/lipoprotein-a
- Zepbound (tirzepatide) injection. FDA prescribing information, Table 3 (cardiometabolic parameters, Studies 1 and 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Wegovy (semaglutide) injection 2.4 mg. FDA prescribing information, Table 10 (cardiometabolic parameters, Study 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Wilson JM, Nikooienejad A, Robins DA, et al. The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes. Diabetes Obes Metab. 2020;22(12):2451-2459. PMID 33462955
- Lupron Depot (leuprolide acetate) 7.5 mg, 22.5 mg, 30 mg, 45 mg. FDA prescribing information: Warnings (metabolic syndrome) and laboratory abnormalities. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5dd
- Zoladex (goserelin implant) 3.6 mg. FDA prescribing information: lipid changes in women treated for endometriosis. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=294b168b-6e5f-4db9-bf70-d599271458b3
Educational information, not medical advice. Lab ranges and test codes were checked on November 2, 2026. Always use the range printed on your own report, and talk to a clinician about your results.